Weight Loss Drugs: What to Know in 2024
Alpha Sense BI
JANUARY 11, 2024
Semaglutide injections, used to treat type 2 diabetes by promoting radical weight loss, are raking in historic profits. Not only has Novo seen record-breaking earnings and share values, but its staggering success put an end to the French luxury group’s two-and-a-half year-long market dominance.
Let's personalize your content